Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Stimulation | 6 | 2022 | 13 | 1.730 |
Why?
|
| Neuralgia | 3 | 2020 | 16 | 1.030 |
Why?
|
| Complex Regional Pain Syndromes | 6 | 2022 | 25 | 1.000 |
Why?
|
| Ganglia, Spinal | 6 | 2022 | 57 | 0.810 |
Why?
|
| Analgesia, Epidural | 7 | 2003 | 57 | 0.590 |
Why?
|
| Chronic Pain | 4 | 2022 | 112 | 0.570 |
Why?
|
| Equipment Failure | 1 | 2016 | 51 | 0.560 |
Why?
|
| Ketamine | 2 | 2018 | 33 | 0.530 |
Why?
|
| Pain, Postoperative | 7 | 2003 | 314 | 0.480 |
Why?
|
| Analgesics | 6 | 2018 | 108 | 0.480 |
Why?
|
| Electric Stimulation Therapy | 4 | 2018 | 44 | 0.420 |
Why?
|
| Low Back Pain | 3 | 2022 | 139 | 0.390 |
Why?
|
| Humans | 39 | 2022 | 29361 | 0.300 |
Why?
|
| Pain, Intractable | 3 | 2007 | 15 | 0.300 |
Why?
|
| Pain Management | 4 | 2018 | 143 | 0.240 |
Why?
|
| Analgesia, Patient-Controlled | 3 | 2003 | 26 | 0.240 |
Why?
|
| Pain | 7 | 2022 | 391 | 0.230 |
Why?
|
| Denmark | 1 | 2020 | 12 | 0.190 |
Why?
|
| Pain Measurement | 8 | 2022 | 462 | 0.190 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2012 | 33 | 0.180 |
Why?
|
| Anesthesia, Epidural | 2 | 2011 | 25 | 0.180 |
Why?
|
| Anesthesiologists | 1 | 2018 | 6 | 0.170 |
Why?
|
| Nerve Block | 4 | 2000 | 62 | 0.160 |
Why?
|
| Spinal Stenosis | 1 | 2018 | 52 | 0.160 |
Why?
|
| Anesthesia, Conduction | 1 | 2018 | 30 | 0.160 |
Why?
|
| Prospective Studies | 7 | 2022 | 1812 | 0.150 |
Why?
|
| Societies, Medical | 1 | 2018 | 190 | 0.140 |
Why?
|
| Testicular Diseases | 1 | 1996 | 12 | 0.140 |
Why?
|
| Spermatic Cord | 1 | 1996 | 13 | 0.140 |
Why?
|
| Denervation | 1 | 1996 | 21 | 0.140 |
Why?
|
| Microsurgery | 1 | 1996 | 40 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 333 | 0.140 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2015 | 11 | 0.130 |
Why?
|
| Consensus | 3 | 2022 | 104 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2022 | 3273 | 0.130 |
Why?
|
| Cohort Studies | 1 | 2020 | 1939 | 0.130 |
Why?
|
| Thoracotomy | 1 | 1994 | 22 | 0.130 |
Why?
|
| Spinal Fusion | 1 | 2022 | 516 | 0.130 |
Why?
|
| Bupivacaine | 3 | 1994 | 54 | 0.130 |
Why?
|
| Lactones | 2 | 2005 | 14 | 0.130 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 52 | 0.130 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2005 | 36 | 0.120 |
Why?
|
| Morphine | 2 | 1992 | 79 | 0.120 |
Why?
|
| Adult | 13 | 2022 | 8604 | 0.110 |
Why?
|
| Middle Aged | 12 | 2022 | 9823 | 0.110 |
Why?
|
| International Normalized Ratio | 1 | 2011 | 23 | 0.100 |
Why?
|
| Catheterization | 1 | 2011 | 51 | 0.100 |
Why?
|
| Warfarin | 1 | 2011 | 37 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 56 | 0.100 |
Why?
|
| Benzocaine | 2 | 2000 | 4 | 0.090 |
Why?
|
| Female | 15 | 2022 | 16211 | 0.090 |
Why?
|
| Narcotics | 1 | 1990 | 34 | 0.090 |
Why?
|
| Psychometrics | 1 | 2010 | 262 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 206 | 0.090 |
Why?
|
| Anesthetics, Local | 2 | 2000 | 91 | 0.080 |
Why?
|
| Neoplasms | 2 | 1998 | 247 | 0.080 |
Why?
|
| Sulfones | 2 | 2005 | 24 | 0.080 |
Why?
|
| Male | 13 | 2022 | 15637 | 0.080 |
Why?
|
| Terrorism | 1 | 2007 | 13 | 0.080 |
Why?
|
| Analgesia | 1 | 2007 | 38 | 0.080 |
Why?
|
| Spinal Cord | 1 | 2007 | 103 | 0.070 |
Why?
|
| Reflex Sympathetic Dystrophy | 2 | 1996 | 6 | 0.070 |
Why?
|
| Infusions, Intravenous | 2 | 2018 | 76 | 0.070 |
Why?
|
| Depressive Disorder | 1 | 2007 | 187 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1113 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2010 | 389 | 0.060 |
Why?
|
| Injections, Epidural | 2 | 2018 | 17 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2022 | 3476 | 0.060 |
Why?
|
| Sympatholytics | 2 | 2010 | 14 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2003 | 50 | 0.060 |
Why?
|
| Clonidine | 2 | 1996 | 31 | 0.060 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 215 | 0.060 |
Why?
|
| Aged | 7 | 2022 | 9447 | 0.060 |
Why?
|
| Sacroiliac Joint | 1 | 2022 | 9 | 0.050 |
Why?
|
| Upper Extremity | 1 | 2022 | 49 | 0.050 |
Why?
|
| Device Removal | 1 | 2022 | 85 | 0.050 |
Why?
|
| Fentanyl | 2 | 1994 | 21 | 0.050 |
Why?
|
| Celiac Plexus | 1 | 2000 | 2 | 0.050 |
Why?
|
| Extremities | 2 | 1996 | 31 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2000 | 142 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 788 | 0.040 |
Why?
|
| Decompression, Surgical | 1 | 2018 | 141 | 0.040 |
Why?
|
| Thermography | 1 | 1996 | 12 | 0.040 |
Why?
|
| Parasympatholytics | 1 | 1996 | 14 | 0.040 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1996 | 15 | 0.040 |
Why?
|
| Blood Pressure | 3 | 1996 | 238 | 0.030 |
Why?
|
| Time Factors | 2 | 1992 | 1618 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2003 | 696 | 0.030 |
Why?
|
| Anesthesia, Spinal | 1 | 2015 | 18 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2015 | 30 | 0.030 |
Why?
|
| Yohimbine | 2 | 1996 | 9 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2018 | 300 | 0.030 |
Why?
|
| Chronic Disease | 4 | 1998 | 495 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 404 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 4851 | 0.030 |
Why?
|
| Patient Care Team | 1 | 1994 | 140 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 1992 | 49 | 0.030 |
Why?
|
| Algorithms | 1 | 1994 | 400 | 0.030 |
Why?
|
| United States | 1 | 2018 | 2332 | 0.030 |
Why?
|
| Oxygen | 1 | 1992 | 85 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2011 | 25 | 0.020 |
Why?
|
| Guanethidine | 1 | 2010 | 1 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 1991 | 56 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 1992 | 79 | 0.020 |
Why?
|
| Vasodilation | 1 | 2010 | 19 | 0.020 |
Why?
|
| Subarachnoid Space | 1 | 1990 | 8 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 67 | 0.020 |
Why?
|
| Nociceptors | 1 | 1990 | 19 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2010 | 78 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 100 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 1935 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 553 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2010 | 330 | 0.020 |
Why?
|
| Subdural Space | 1 | 1988 | 2 | 0.020 |
Why?
|
| Embolism, Air | 1 | 1988 | 9 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2007 | 26 | 0.020 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2007 | 11 | 0.020 |
Why?
|
| Causality | 1 | 2007 | 53 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 965 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 144 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2003 | 503 | 0.020 |
Why?
|
| Patient Selection | 1 | 2007 | 232 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 168 | 0.020 |
Why?
|
| Adaptation, Psychological | 2 | 1996 | 143 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2005 | 66 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2005 | 140 | 0.020 |
Why?
|
| Prognosis | 1 | 2007 | 840 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 189 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2007 | 678 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2007 | 957 | 0.020 |
Why?
|
| Dyssomnias | 1 | 2003 | 8 | 0.020 |
Why?
|
| Stress, Psychological | 2 | 1996 | 246 | 0.020 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 25 | 0.010 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2003 | 18 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 30 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2003 | 29 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2003 | 64 | 0.010 |
Why?
|
| Injections, Spinal | 2 | 1996 | 47 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2003 | 52 | 0.010 |
Why?
|
| Reaction Time | 2 | 1996 | 123 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 1251 | 0.010 |
Why?
|
| Hemodynamics | 2 | 1996 | 83 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 173 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 1988 | 487 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 1988 | 606 | 0.010 |
Why?
|
| Adolescent | 1 | 1988 | 2280 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 295 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2003 | 699 | 0.010 |
Why?
|
| Suspensions | 1 | 1998 | 4 | 0.010 |
Why?
|
| Syndrome | 1 | 1998 | 82 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1996 | 9 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1996 | 18 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 56 | 0.010 |
Why?
|
| Body Temperature | 1 | 1996 | 58 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1996 | 20 | 0.010 |
Why?
|
| Biofeedback, Psychology | 1 | 1996 | 3 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1996 | 20 | 0.010 |
Why?
|
| Pain Clinics | 1 | 1996 | 4 | 0.010 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1996 | 20 | 0.010 |
Why?
|
| Behavior | 1 | 1996 | 27 | 0.010 |
Why?
|
| Dioxanes | 1 | 1996 | 3 | 0.010 |
Why?
|
| Idazoxan | 1 | 1996 | 3 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 1996 | 14 | 0.010 |
Why?
|
| Glycopyrrolate | 1 | 1996 | 5 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 9 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 1996 | 28 | 0.010 |
Why?
|
| Bradycardia | 1 | 1996 | 28 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 1996 | 100 | 0.010 |
Why?
|
| Physical Therapy Modalities | 1 | 1996 | 80 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 1996 | 82 | 0.010 |
Why?
|
| Learning | 1 | 1996 | 79 | 0.010 |
Why?
|
| Dogs | 1 | 1996 | 253 | 0.010 |
Why?
|
| Wakefulness | 1 | 1996 | 80 | 0.010 |
Why?
|
| Imidazoles | 1 | 1996 | 72 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 364 | 0.010 |
Why?
|
| Family | 1 | 1996 | 88 | 0.010 |
Why?
|
| Heart Rate | 1 | 1996 | 142 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 437 | 0.010 |
Why?
|
| Animals | 2 | 1996 | 4577 | 0.010 |
Why?
|
| Reperfusion | 1 | 1992 | 7 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1992 | 21 | 0.010 |
Why?
|
| Oximetry | 1 | 1992 | 11 | 0.010 |
Why?
|
| Hypotension | 1 | 1992 | 27 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1992 | 43 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1992 | 64 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1992 | 92 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1996 | 1184 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1992 | 112 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 34 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1988 | 13 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1988 | 52 | 0.010 |
Why?
|
| Epidural Space | 1 | 1988 | 24 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1988 | 83 | 0.010 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 1988 | 3 | 0.010 |
Why?
|
| Veins | 1 | 1988 | 8 | 0.010 |
Why?
|
| Random Allocation | 1 | 1988 | 146 | 0.000 |
Why?
|
| Cognition | 1 | 1996 | 1279 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1988 | 41 | 0.000 |
Why?
|
| Rats | 1 | 1990 | 858 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1988 | 226 | 0.000 |
Why?
|
| Incidence | 1 | 1988 | 756 | 0.000 |
Why?
|
| Hip Joint | 1 | 1988 | 367 | 0.000 |
Why?
|